60Nd
NeoMag is the first magneto-mechanical platform that simulates pathological processes in biological systems for more predictive drug testing in a non-invasive, contact-free and portable by design way.
60Nd has raised €2.4M across 1 funding round from 1 investor, most recently a round in Feb 2026. Based in Madrid, Spain; active in Healthtech. Data as of 28 Oct 2026.
Madrid, Spainwww.60nd.bio ↗
Total raised
€2.4M
€2,400,000
Funding rounds
1
Investors
1
distinct backers
Active since
2026-02
latest 2026-02
Funding by year
EUR raised per year · 2026 YTD60Nd — funding by year — interactive chart.
Data table
| 60Nd — funding by year | |
|---|---|
| 2026 | €2.4M |
Signals
High confidenceRaise-next likelihood31
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-02-19 | Other | €2.4M | EIC Transition | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData